COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) ('Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results